These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10386679)

  • 21. Treatment of acute stroke with recombinant tissue plasminogen activator and abciximab.
    Morris DC; Silver B; Mitsias P; Lewandowski C; Patel S; Daley S; Zhang ZG; Lu M
    Acad Emerg Med; 2003 Dec; 10(12):1396-9. PubMed ID: 14644794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Logistics in acute stroke management.
    Broderick JP
    Drugs; 1997; 54 Suppl 3():109-16; discussion 116-7. PubMed ID: 9360858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accuracy of First Recorded "Last Known Normal" Times of Stroke Code Patients.
    Spokoyny I; Raman R; Ernstrom K; Kim AJ; Meyer BC; Karanjia NP
    J Stroke Cerebrovasc Dis; 2015 Nov; 24(11):2467-73. PubMed ID: 26341734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Twelve-month experience of acute stroke thrombolysis in Christchurch, New Zealand: emergency department screening and acute stroke service treatment.
    Fink J
    N Z Med J; 2005 May; 118(1214):U1430. PubMed ID: 15886726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of in-hospital mortality and the risk of symptomatic intracerebral hemorrhage after thrombolytic therapy with recombinant tissue plasminogen activator in acute ischemic stroke.
    Al-Khaled M; Matthis C; Eggers J
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):7-11. PubMed ID: 22578915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Misdiagnosis of stroke in tissue plasminogen activator-treated patients: characteristics and outcomes.
    Scott PA; Silbergleit R
    Ann Emerg Med; 2003 Nov; 42(5):611-8. PubMed ID: 14581912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue plasminogen activator (rt-PA) in acute ischemic stroke: Outcomes associated with ambulation.
    Lawson TR; Brown IE; Westerkam DL; Blackhurst DW; Sternberg S; Leacock R; Nathaniel TI
    Restor Neurol Neurosci; 2015; 33(3):301-8. PubMed ID: 25698111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accuracy of Stroke Diagnosis in Telestroke-Guided Tissue Plasminogen Activator Patients.
    Agrawal K; Raman R; Ernstrom K; Claycomb RJ; Meyer DM; Hemmen TM; Modir RF; Kachhi P; Meyer BC
    J Stroke Cerebrovasc Dis; 2016 Dec; 25(12):2942-2946. PubMed ID: 27599906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.
    Mori M; Naganuma M; Okada Y; Hasegawa Y; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Kario K; Okuda S; Koga M; Minematsu K; Toyoda K
    Cerebrovasc Dis; 2012; 34(2):140-6. PubMed ID: 22854333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Intravenous thrombolysis patients with acute ischemic stroke: the analysis of the 100 cases. Part I. Characteristic of the patients and effectiveness of treatment].
    Sobolewski P; Sledzińska M; Szczuchniak W; Hatalska-Zerebiec R; Grzesik M; Sobota A
    Przegl Lek; 2012; 69(6):237-41. PubMed ID: 23094435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ginsenoside Represses Symptomatic Intracerebral Hemorrhage after Recombinant Tissue Plasminogen Activator Therapy by Promoting Transforming Growth Factor-β1.
    Chen J; Bai Q; Zhao Z; Sui H; Xie X
    J Stroke Cerebrovasc Dis; 2016 Mar; 25(3):549-55. PubMed ID: 26683593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke?
    Shaltoni HM; Albright KC; Gonzales NR; Weir RU; Khaja AM; Sugg RM; Campbell MS; Cacayorin ED; Grotta JC; Noser EA
    Stroke; 2007 Jan; 38(1):80-4. PubMed ID: 17122433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved door-to-needle times and neurologic outcomes when IV tissue plasminogen activator is administered by emergency physicians with advanced neuroscience training.
    Greenberg K; Maxwell CR; Moore KD; D'Ambrosio M; Liebman K; Veznedaroglu E; Sanfillippo G; Diaz C; Binning MJ
    Am J Emerg Med; 2015 Feb; 33(2):234-7. PubMed ID: 25498530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of serum lipid levels on stroke outcome after rt-PA therapy: SAMURAI rt-PA registry.
    Makihara N; Okada Y; Koga M; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Hasegawa Y; Kario K; Okuda S; Naganuma M; Toyoda K
    Cerebrovasc Dis; 2012; 33(3):240-7. PubMed ID: 22261711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A systems approach to immediate evaluation and management of hyperacute stroke. Experience at eight centers and implications for community practice and patient care. The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group.
    Stroke; 1997 Aug; 28(8):1530-40. PubMed ID: 9259745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of t-PA use for acute ischemic stroke in a community hospital: high incidence of exclusion criteria.
    Engelstein E; Margulies J; Jeret JS
    Am J Emerg Med; 2000 May; 18(3):257-60. PubMed ID: 10830678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute stroke care in the US: results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry.
    Reeves MJ; Arora S; Broderick JP; Frankel M; Heinrich JP; Hickenbottom S; Karp H; LaBresh KA; Malarcher A; Mensah G; Moomaw CJ; Schwamm L; Weiss P;
    Stroke; 2005 Jun; 36(6):1232-40. PubMed ID: 15890989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergency department evaluation of ischemic stroke and TIA: the BASIC Project.
    Brown DL; Lisabeth LD; Garcia NM; Smith MA; Morgenstern LB
    Neurology; 2004 Dec; 63(12):2250-4. PubMed ID: 15623682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feasibility and safety of remote radiology interpretation with telephone consultation for acute stroke in Thailand.
    Muengtaweepongsa S; Dharmasaroja PA; Maungboon P; Wattanaruangkowit P
    Neurol India; 2010; 58(5):740-2. PubMed ID: 21045500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment.
    Huang Y; Sharma VK; Robinson T; Lindley RI; Chen X; Kim JS; Lavados P; Olavarría V; Arima H; Fuentes S; Nguyen HT; Lee TH; Parsons MW; Levi C; Demchuk AM; Bath PM; Broderick JP; Donnan GA; Martins S; Pontes-Neto OM; Silva F; Pandian J; Ricci S; Stapf C; Woodward M; Wang J; Chalmers J; Anderson CS;
    Int J Stroke; 2015 Jul; 10(5):778-88. PubMed ID: 25832995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.